User profiles for Tianlin He
Tianlin HEMosaiques Diagnostics GmbH Verified email at mosaiques.de Cited by 205 |
[HTML][HTML] Role of hypoxia in the tumor microenvironment and targeted therapy
G Chen, K Wu, H Li, D Xia, T He - Frontiers in oncology, 2022 - frontiersin.org
Tumor microenvironment (TME), which is characterized by hypoxia, widely exists in solid
tumors. As a current research hotspot in the TME, hypoxia is expected to become a key element …
tumors. As a current research hotspot in the TME, hypoxia is expected to become a key element …
Proteomic biomarkers in the cardiorenal syndrome: Toward deciphering molecular pathophysiology
Cardiorenal syndrome (CRS) is defined by coexisting heart and renal dysfunctions.
Malfunction of 1 organ may cause dysfunction of the other with variable causative disease that …
Malfunction of 1 organ may cause dysfunction of the other with variable causative disease that …
Prion protein and cancers
X Yang, Y Zhang, L Zhang, T He… - Acta Biochim Biophys …, 2014 - academic.oup.com
The normal cellular prion protein, PrP C is a highly conserved and widely expressed cell
surface glycoprotein in all mammals. The expression of PrP is pivotal in the pathogenesis of …
surface glycoprotein in all mammals. The expression of PrP is pivotal in the pathogenesis of …
Urinary peptides in heart failure: a link to molecular pathophysiology
T He, M Mischak, AL Clark, RT Campbell… - European Journal of …, 2021 - Wiley Online Library
Aims Heart failure (HF) is a major public health concern worldwide. The diversity of HF
makes it challenging to decipher the underlying complex pathological processes using single …
makes it challenging to decipher the underlying complex pathological processes using single …
[HTML][HTML] Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer
B Zhao, T He - Oncology reports, 2015 - spandidos-publications.com
Chidamide is a newly designed histone deacetylase (HDAC) inhibitor that has been applied
in clinical trials. This study aimed to test the effect of Chidamide on proliferation and …
in clinical trials. This study aimed to test the effect of Chidamide on proliferation and …
Peptides in plasma, urine, and dialysate: toward unravelling renal peptide handling
Purpose The peptidomes of spent hemodialysate, urine, and plasma are investigated, to shed
light on peptide handling in the kidney. Experimental Design Fifteen plasma, 15 urine, and …
light on peptide handling in the kidney. Experimental Design Fifteen plasma, 15 urine, and …
Gambogic acid inhibits the progression of gastric cancer via circRNA_ASAP2/miR-33a-5p/CDK7 axis
D Lin, X Lin, T He, G Xie - Cancer management and research, 2020 - Taylor & Francis
Background Gastric cancer (GC) is a major cancer-related mortality disease. Gambogic acid
(GA) has been investigated to inhibit cancer progression. In the present study, the molecular …
(GA) has been investigated to inhibit cancer progression. In the present study, the molecular …
CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?
Identification of significant changes in urinary peptides may enable improved understanding
of molecular disease mechanisms. We aimed towards identifying urinary peptides …
of molecular disease mechanisms. We aimed towards identifying urinary peptides …
[HTML][HTML] The c-Myc–LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
TL He, YJ Zhang, H Jiang, X Li, H Zhu, KL Zheng - Medical Oncology, 2015 - Springer
The transcription factor c-Myc plays critical roles in cancer development and progression
through regulating expression of targeted genes. Lactate dehydrogenase A (LDHA), which …
through regulating expression of targeted genes. Lactate dehydrogenase A (LDHA), which …
Implementation of proteomics in clinical trials
T He - PROTEOMICS–Clinical Applications, 2019 - Wiley Online Library
The application of protein (or peptide) biomarkers in clinical studies is a dynamic, ever‐growing
field. The introduction of clinical proteomics/peptidomics, such as mass spectrometry–…
field. The introduction of clinical proteomics/peptidomics, such as mass spectrometry–…